We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 5.25
Ask: 5.50
Change: -0.25 (-4.44%)
Spread: 0.25 (4.762%)
Open: 5.625
High: 5.625
Low: 5.375
Prev. Close: 5.625
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Feb 2020 16:45

RNS Number : 1157C
Genedrive PLC
05 February 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Genedrive Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)

3. Details of person subject to the notification obligationiv

Name

M&G Plc

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

04/02/2020

6. Date on which issuer notified (DD/MM/YYYY):

05/02/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

13.27%

0.00%

13.27%

34,870,071

Position of previous notification (if

applicable)

14.78%

0.00%

14.78%

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD GBP0.015 GB00B1VKB244

4,630,643

13.27%

SUBTOTAL 8. A

4,630,643

13.27%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

M&G Plc (Parent Company)

13.27%

0.00%

13.27%

M&G Group Limited

(wholly owned subsidiary of M&G Plc)

13.27%

0.00%

13.27%

M&G FA Limited

(wholly owned subsidiary of M&G Group Limited)

13.27%

0.00%

13.27%

M&G Investment

Management Limited

(wholly owned subsidiary of M&G FA Limited)

13.27%

0.00%

13.27%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

London, United Kingdom

Date of completion

5th February 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFLFSRFLIEIII
Date   Source Headline
20th Nov 20207:00 amRNSHigh clinical accuracy in India study
17th Nov 20207:00 amRNSFinal Results
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20204:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSNotice of Results
28th Oct 20204:41 pmRNSSecond Price Monitoring Extn
28th Oct 20204:36 pmRNSPrice Monitoring Extension
22nd Oct 20207:00 amRNSPoint-of-Care solution to detect SARS-CoV-2 virus
19th Oct 202012:44 pmRNSHolding(s) in Company
12th Oct 202011:18 amRNSHolding(s) in Company
9th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
1st Oct 20206:09 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSSouth African approval
28th Sep 20207:00 amRNSPartial Conversion of Loan Notes
25th Sep 20207:00 amRNSVerification with Beckman Coulter Life Sciences
21st Sep 20209:40 amRNSHolding(s) in Company
18th Sep 20202:06 pmRNSSecond Price Monitoring Extn
18th Sep 20202:01 pmRNSPrice Monitoring Extension
17th Sep 20209:27 amRNSHolding(s) in Company
16th Sep 20203:15 pmRNSHolding(s) in Company
16th Sep 20209:00 amRNSHolding(s) in Company
15th Sep 20201:12 pmRNSHolding(s) in Company
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSHolding(s) in Company
4th Aug 20202:05 pmRNSSecond Price Monitoring Extn
4th Aug 20202:00 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSCollaboration to automate COVID-19 PCR testing
23rd Jul 202011:06 amRNSSecond Price Monitoring Extn
23rd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20203:13 pmRNSHolding(s) in Company
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
16th Jul 20204:29 pmRNSHolding(s) in Company
13th Jul 20209:00 amRNSPrice Monitoring Extension
10th Jul 20202:05 pmRNSSecond Price Monitoring Extn
10th Jul 20202:00 pmRNSPrice Monitoring Extension
10th Jul 20207:01 amRNSNew Genedrive® 96 Exporter software
10th Jul 20207:00 amRNSTrading update
1st Jul 20207:00 amRNSTotal Voting Rights
26th Jun 20203:24 pmRNSHolding(s) in Company
25th Jun 20203:39 pmRNSHolding(s) in Company
22nd Jun 20203:06 pmRNSHolding(s) in Company
22nd Jun 202011:08 amRNSHolding(s) in Company
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
17th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.